Style | Citing Format |
---|---|
MLA | Mehrtabar E, et al.. "Impact of Microrna Variants on Pi3k/Akt Signaling in Triple-Negative Breast Cancer: Comprehensive Review." Medical Oncology, vol. 41, no. 9, 2024, pp. -. |
APA | Mehrtabar E, Khalaji A, Pandeh M, Farhoudian A, Shafiee N, Shafiee A, Ojaghlou F, Mahdavi P, Soleymanigoloujeh M (2024). Impact of Microrna Variants on Pi3k/Akt Signaling in Triple-Negative Breast Cancer: Comprehensive Review. Medical Oncology, 41(9), -. |
Chicago | Mehrtabar E, Khalaji A, Pandeh M, Farhoudian A, Shafiee N, Shafiee A, Ojaghlou F, Mahdavi P, Soleymanigoloujeh M. "Impact of Microrna Variants on Pi3k/Akt Signaling in Triple-Negative Breast Cancer: Comprehensive Review." Medical Oncology 41, no. 9 (2024): -. |
Harvard | Mehrtabar E et al. (2024) 'Impact of Microrna Variants on Pi3k/Akt Signaling in Triple-Negative Breast Cancer: Comprehensive Review', Medical Oncology, 41(9), pp. -. |
Vancouver | Mehrtabar E, Khalaji A, Pandeh M, Farhoudian A, Shafiee N, Shafiee A, et al.. Impact of Microrna Variants on Pi3k/Akt Signaling in Triple-Negative Breast Cancer: Comprehensive Review. Medical Oncology. 2024;41(9):-. |
BibTex | @article{ author = {Mehrtabar E and Khalaji A and Pandeh M and Farhoudian A and Shafiee N and Shafiee A and Ojaghlou F and Mahdavi P and Soleymanigoloujeh M}, title = {Impact of Microrna Variants on Pi3k/Akt Signaling in Triple-Negative Breast Cancer: Comprehensive Review}, journal = {Medical Oncology}, volume = {41}, number = {9}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Mehrtabar E AU - Khalaji A AU - Pandeh M AU - Farhoudian A AU - Shafiee N AU - Shafiee A AU - Ojaghlou F AU - Mahdavi P AU - Soleymanigoloujeh M TI - Impact of Microrna Variants on Pi3k/Akt Signaling in Triple-Negative Breast Cancer: Comprehensive Review JO - Medical Oncology VL - 41 IS - 9 SP - EP - PY - 2024 ER - |